or Try an Advanced Search...

    Molecule Product Stocks List

    Symbol Grade Name % Change
    IMUX C Immunic, Inc. 0.00
    KROS D Keros Therapeutics, Inc. 0.00
    RARE F Ultragenyx Pharmaceutical Inc. 0.00
    OCUP F Ocuphire Pharma, Inc. 0.00
    VTYX F Ventyx Biosciences, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Autoimmune Disease Clinical Medicine Organ Systems Psoriasis Rare Diseases Ulcerative Colitis Abdominal Pain Acid Anemia Angiogenesis Autoimmune Disorders Biologics Biotechnology Blindness Bone Bone Disease Clinical Development Colitis Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Molecule Product stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 4.6
    TMFS A Motley Fool Small-Cap Growth ETF 2.92
    TMFM B Motley Fool Mid-Cap Growth ETF 2.04
    BBP C BioShares Biotechnology Products Fund 1.86
    XBI D SPDR S&P Biotech ETF 1.77
    View all Molecule Product ETFs...
    Compare ETFs
    Compare TMFM to BBP Compare TMFS to BBP Compare TMFS to XBI

        Molecule Product Stocks Recent News

        Date Stock Title
        May 8 IMUX Immunic, Inc. (IMUX) Q1 2024 Earnings Call Transcript
        May 8 IMUX Immunic, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 8 IMUX Immunic GAAP EPS of -$0.30 misses by $0.04
        May 8 IMUX Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 7 RARE Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference
        May 7 IMUX Immunic Q1 2024 Earnings Preview
        May 6 OCUP Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
        May 6 IMUX Immunic to Participate in Investor and Scientific Conferences in May
        May 4 RARE Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
        May 4 RARE Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
        May 3 RARE Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
        May 3 KROS Keros Therapeutics files automatic mixed shelf
        May 3 RARE Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
        May 3 OCUP Ocuphire Pharma to Present at the Aegis Virtual Conference
        May 3 RARE Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2024 Earnings Call Transcript
        May 2 RARE Ultragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...
        May 2 VTYX Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
        May 2 RARE Ultragenyx Pharmaceutical GAAP EPS of -$2.03 misses by $0.28, revenue of $108.8M misses by $7.64M
        May 2 RARE Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Autoimmune Disease Clinical Medicine Organ Systems Psoriasis Rare Diseases Ulcerative Colitis Abdominal Pain Acid Anemia Angiogenesis Autoimmune Disorders Biologics Biotechnology Blindness Bone Bone Disease Clinical Development Colitis Crohn's Disease
        Molecule Product

        Molecule products are products that are made up of molecules. Molecules are the smallest particles of a substance that can exist on their own and still retain the properties of that substance. Examples of molecule products include pharmaceuticals, cosmetics, food additives, and cleaning products.

        Browse All Tags